Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
WASHINGTON–A Boston consumer group filed a class-action suit Thursday against Schering-Plough Corporation, the maker of Claritin, alleging the company has used deceptive and unfair advertising to increase demand for the drug.
The Prescription Access Litigation Project filed the suit in Superior Court in New Jersey. “We believe Schering-Plough has deliberately left out any information about the drug?s efficacy, instead serving up glowing ads to push this product in America?s living rooms,” said Stephen Rosenfeld, the group’s spokesman.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in